Two toxicologists from ToxStrategies’ Pharmaceuticals practice are among the team with a new publication concerning the use of in silico (computer modeling) approaches… read more

This gallery contains 1 photo.

ToxStrategies toxicologist Dr. Rayetta Henderson served on a panel that briefed both the US House and Senate on the future regulation of CBD… read more

This gallery contains 1 photo.

ToxStrategies scientists Julie Panko, Liz Mittal, and Kara Franke assessed potential worker exposures to 1,3-butadiene during chemical manufacturing and processing of the substance… read more

This gallery contains 1 photo.

ToxStrategies’ scientists Camarie Perry and Deborah Proctor conducted a regulatory and scientific literature review to develop an acute/short-term inhalation guideline for manganese in… read more

ToxStrategies’ scientists will be participating in The Society of Environmental Toxicology and Chemistry’s (SETAC) 44th Annual Meeting this year, November 12–16, in Louisville,… read more

HEORStrategies provides robust, strategic health economics and outcomes research (HEOR) consulting services to pharma, biotech, and medical device clients!

EpidStrategies’ scientists are recognized experts in the field of respiratory syncytial virus (RSV). Our RSV research program supported the newly-approved monoclonal antibody with… read more

This gallery contains 2 photos.

ToxStrategies scientist Dr. Rayetta Henderson is among the authors of two new articles published by the journal Cannabis and Cannabinoid Research. Together, these… read more